"Accelerated phase" chronic lymphocytic leukemia: Still an intermediate risk disease in the era of targeted therapies. Issue 4 (8th March 2022) - Lapierre, Léopoldine; Syrykh, Charlotte; Largeaud, Laetitia; Cabarrou, Bastien; Filleron, Thomas; Oberic, Lucie; Kanoun, Salim; Coster, Lucie; Laurent, Camille; Branco, Benoît; Gadaud, Noémie; Récher, Christian; et al.